Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3205-3212

  Du, Peng ^a,b   Ye, Lin ^a   Ruge, Fiona ^a   Yang, Yong ^b   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Cellular migration; Invasion; Metastasis; Metastasis suppressor 1; MTSS1

Indexed keywords

METASTASIS SUPPRESSOR 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL-MATRIX JUNCTIONS; ELECTRIC IMPEDANCE; HUMANS; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 80054733240     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brandau S and Bohle A: Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol 39: 491-497, 2001. (Pubitemid 32678962)
2. Malik FA, Sanders AJ, Jones AD, Mansel RE and Jiang WG: Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance. Int J Mol Med 23: 273-278, 2009.
3. Malik FA, Sanders AJ, Kayani MA and Jiang WG: Effect of expressional alteration of KAI1 on breast cancer cell growth, adhesion, migration and invasion. Cancer Genomics Proteomics 6: 205-213, 2009.
4. Steeg PS: Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3: 55-63, 2003.
5. Lee YG, Macoska JA, Korenchuk S and Pienta KJ: MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4: 291-294, 2002. (Pubitemid 34755838)
6. Woodings JA, Sharp SJ and Machesky LM: MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J 371: 463-471, 2003. (Pubitemid 36547630)
7. Mattila PK, Salminen M, Yamashiro T and Lappalainen P: Mouse MIM, a tissue-specific regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain. J Biol Chem 278: 8452-8459, 2003. (Pubitemid 36800596)
8. Ma S, Guan XY, Lee TK and Chan KW: Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol 38: 1201-1206, 2007. (Pubitemid 47058158)
9. Parr C and Jiang WG: Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer 45: 1673-1683, 2009.
10. Xie F, Ye L, Chen J, Wu N, Zhang Z, Yang Y, Zhang L and Jiang WG: The impact of metastasis suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance. J Transl Med 9: 95-104, 2011.
11. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mansel RE and Mason MD: The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo. Int J Mol Med 16: 723-728, 2005.
12. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF and Puntis MC: Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer 71: 744-752, 1995.
13. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD and Mansel RE: Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17: 583-590, 2006.
14. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K and Mansel RE: Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 11: 6012-6019, 2005. (Pubitemid 41170333)
15. 2+. Exp Cell Res 220: 424-433, 1995.
16. Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer 7: 71-80, 2008.
17. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011. CA Cancer J Clin 61: 212-236, 2011.
18. Ploeg M, Aben KK and Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol 27: 289-293, 2009.
19. Epstein JI, Amin MB, Reuter VR and Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22: 1435-1448, 1998. (Pubitemid 28550639)
20. Oyasu R: World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors. Cancer 88: 1509-1512, 2000.
21. Youssef RF and Lotan Y: Predictors of outcome of non-muscle-invasive and muscle-invasive bladder cancer. Scientific World J 11: 369-381, 2011.
22. Utikall J GA, Muller-Molinet I, Oerther S, Kzhyshkowska J, Arens N, Grobholz R, Kannookadan S and Goerdt S: The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation. Int J Cancer 119: 2287-2293, 2006. (Pubitemid 44546947)